Create a free account to find warm leads

With Highperformr, you can:

Discover ready-to-buy prospects using real-time intent signals
Find companies and people that match your ideal customer profile
Enrich your data with verified emails, social profiles, and more
and much more...

Already have account?

Martin Tolar, MD, PhD Email & Phone Number

Founder & Director,

Cambridge

United States

View Martin Tolar, MD, PhD’s Email & Phone Number for FREE

100 FREE credits to access up to 50 email addresses

Martin's contact information

Martin’s email address

XXXX@XX.XX

Email address

Martin’s phone numbers

Phone number

Unlock contact information

Buyer intent signals for Martin

A “Signal” in Highperformr AI delivers actionable insights to help your sales, marketing and GTM team prioritize and engage the right prospects. Uncover opportunities, and make smarter decisions.

Decision Maker

ICP Match

Recent Promotion

Leadership

Prouilding

Corpnance

Cte Finance

Corporate Finance

*Example signal, not calculated in real time

See signals

Martin’s work information

Founder & Director

now

Martin’s education information

Martin’s skills

Leadership

Product building

Corporate Finance

FAQ about Martin

What is Martin email address?

Email Martin Tolar, MD, PhD at XXXX@XXX.XX. This email is the most updated Martin Tolar, MD, PhD's email found in 2024.

Unlock contact information

What is Martin's phone number?

Martin's phone number is .

Unlock contact information

Summary

Martin Tolar, based in Cambridge, Massachusetts, United States, is the Founder, President & CEO at Alzheon, Inc. He also serves as the Founder & Director at Tolion Health, Inc. and founded the International Neurodegenerative Disorders Research Center (INDRC). Previously, Dr. Tolar held executive positions including President & CEO at Knome, Inc., where he developed human genome interpretation systems, and President & CEO at NormOxys, Inc., focusing on novel cancer therapeutics. He also served as CSO and CBO at CoMentis, Inc., where he developed a clinical beta secretase inhibitor platform and negotiated a significant deal with Astellas Pharma. Earlier in his career, he held clinical development and business leadership roles at Pfizer. Dr. Tolar's academic background includes serving as an Assistant Professor in the Department of Neurology at Yale University School of Medicine, specializing in movement disorders. He received his M.D. from Charles University in Prague and earned a Ph.D. in Neuroscience, focusing on apolipoprotein E's role in Alzheimer’s disease. Dr. Tolar has been recognized as one of the Top 100 Most Influential People in drug development by The Medicine Maker Magazine multiple times and received the Czech Laurels Award for his contributions to Alzheimer’s disease therapeutics.